Corey Costa, PA

Corey Costa practices at Wellnow Urgent Care in Springville, New York.

Corey Costa's NPI, 1891266102, was assigned on December 13, 2018.

Corey Costa's primary practice is Wellnow Urgent Care, at 225 S Cascade Dr, Springville, NY 14141 in Erie County. The practice phone is (716) 699-9032.

Corey Costa's primary practice is Wellnow Urgent Care in Springville, New York. The medical group on file is General Physician. Dmand AI also links Corey Costa to 6 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Corey Costa practices. Vendor and product names are available with a free account.

Physician assistant is Corey Costa's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Corey Costa has a license on file in New York.

Dmand AI lists acute sinusitis, acute skin infection, alzheimer's disease, ankle or foot injury, anxiety, asthma, bipolar disorder and broken or dislocated ankle/ or foot among the conditions Corey Costa treats.

CMS data shows 1,010 Medicare services from Corey Costa across 3 procedure codes in 2024, for 207 Medicare patients. Medicare paid $62,781 for them.

CMS counts 207 Medicare patients who saw Corey Costa in 2024. The largest group is 65 to 74, with 68 patients. 75% of them have high blood pressure, and 70% have mood disorders. 91% are also on Medicaid. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Corey Costa's median patient age at 78, with 63% women.

In 2024, Corey Costa wrote 3,600 Medicare Part D claims for 166 patients. 89% of them were for generic drugs. CMS names the drug for 3,530 of them, across 30 drugs with 11 or more claims each, at $702,839 in total drug cost.

Corey Costa accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 23 general payments to Corey Costa from 3 drug and device companies in 2025. Food and beverage make up the largest share, 90% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $724.